Vianello et al. [29] found that high levels of BNIP3 expression significantly reduced survival in ovarian cancer patients, and that BNIP3 affected tumor cell resistance by regulating mitochondrial autophagy and could also be a potential target for new therapeutic strategies. Here, BNIP3 is linked to ovarian cancer.